{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:40:00Z","timestamp":1778866800078,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-24683839"],"award-info":[{"award-number":["RS-2025-24683839"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00222838"],"award-info":[{"award-number":["RS-2023-00222838"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejca.2026.116593","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:55:15Z","timestamp":1771433715000},"page":"116593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach"],"prefix":"10.1016","volume":"237","author":[{"given":"Jeong Ha","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Il","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-9681","authenticated-orcid":false,"given":"Hee Chul","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungkoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong Geun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Ji","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9578-8424","authenticated-orcid":false,"given":"Wonseok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hyun","family":"Sinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geum-Youn","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Hyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Han","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon Seok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minsuk","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1363-9332","authenticated-orcid":false,"given":"Jung Yong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyu-Seong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0676-2116","authenticated-orcid":false,"given":"Woo Kyoung","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Ho","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Yun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2026.116593_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2014.09.001","article-title":"Epidemiology of hepatocellular carcinoma","volume":"24","author":"Lafaro","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"10.1016\/j.ejca.2026.116593_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116593_bib3","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: The LEGACY Study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejca.2026.116593_bib4","first-page":"158","article-title":"The impact of radiation dose and tumour burden on outcomes in hepatocellular carcinoma: 11-year experience in a 413-patient cohort treated with yttrium-90 resin microsphere Radioembolisation","volume":"14","author":"Chen","year":"2025","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejca.2026.116593_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","article-title":"Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence","volume":"72","author":"Raoul","year":"2019","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.ejca.2026.116593_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2021.09.004","article-title":"External beam radiation therapy for primary liver cancers: an ASTRO clinical practice guideline","volume":"12","author":"Apisarnthanarax","year":"2022","journal-title":"Pr Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116593_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3857\/roj.2024.00108","article-title":"Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 4: Liver and locally recurrent rectal cancer","volume":"42","author":"Byun","year":"2024","journal-title":"Radiat Oncol J"},{"issue":"5","key":"10.1016\/j.ejca.2026.116593_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/liv.12445","article-title":"The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma","volume":"34","author":"Cho","year":"2014","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.ejca.2026.116593_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4254\/wjh.v7.i1.101","article-title":"Role of radiotherapy in the management of hepatocellular carcinoma: a systematic review","volume":"7","author":"Kalogeridi","year":"2015","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116593_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijrobp.2012.08.043","article-title":"Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities","volume":"87","author":"Klein","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejca.2026.116593_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000367766","article-title":"Consensus for radiotherapy in hepatocellular carcinoma from the 5th Asia-Pacific primary liver cancer expert meeting (apple 2014): current practice and future clinical trials","volume":"5","author":"Park","year":"2016","journal-title":"Liver Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116593_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17998\/jlc.2025.02.03","article-title":"A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024","volume":"25","author":"Shin","year":"2025","journal-title":"J Liver Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2026.116593_bib13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejca.2026.116593_bib14","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","article-title":"Hepatic toxicity resulting from cancer treatment","volume":"31","author":"Lawrence","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.ejca.2026.116593_bib15","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/cncr.25809","article-title":"The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial","volume":"117","author":"Bush","year":"2011","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2026.116593_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","article-title":"Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial","volume":"74","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116593_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3857\/roj.2017.00409","article-title":"Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma","volume":"36","author":"Yu","year":"2018","journal-title":"Radiat Oncol J"},{"issue":"4","key":"10.1016\/j.ejca.2026.116593_bib18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3350\/cmh.2023.0274","article-title":"Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma","volume":"29","author":"Lee","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ejca.2026.116593_bib19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3389\/fonc.2020.00542","article-title":"Phase II study of hypofractionated proton beam therapy for hepatocellular carcinoma","volume":"10","author":"Kim","year":"2020","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116593_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.21037\/jgo.2019.08.03","article-title":"Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation","volume":"10","author":"Hasan","year":"2019","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116593_bib21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-Institutional Phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116593_bib22","article-title":"BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update","author":"Reig","year":"2025","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.ejca.2026.116593_bib23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3348\/kjr.2022.0822","article-title":"2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma","volume":"23","author":"KLC","year":"2022","journal-title":"Korean J Radiol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116593_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210730","article-title":"Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients","volume":"14","author":"Sinn","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2026.116593_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2020.02.019","article-title":"Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma","volume":"146","author":"Yoo","year":"2020","journal-title":"Radio Oncol"},{"key":"10.1016\/j.ejca.2026.116593_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2022.09.003","article-title":"A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases","volume":"176","author":"Kim","year":"2022","journal-title":"Radio Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116593_bib27","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.21873\/anticanres.17029","article-title":"Proton beam radiotherapy as a curative alternative to radiofrequency ablation for newly diagnosed hepatocellular Carcinoma","volume":"44","author":"Seo","year":"2024","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2026.116593_bib28","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2022044","article-title":"The impact of COVID-19 on cancer care in a tertiary hospital in Korea: possible collateral damage to emergency care","volume":"44","author":"Yoo","year":"2022","journal-title":"Epidemiol Health"},{"issue":"3","key":"10.1016\/j.ejca.2026.116593_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1078\/0939-3889-00217","article-title":"The clinical potential of intensity modulated proton therapy","volume":"14","author":"Lomax","year":"2004","journal-title":"Z Med Phys"},{"issue":"2","key":"10.1016\/j.ejca.2026.116593_bib30","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.ijrobp.2011.05.011","article-title":"A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties","volume":"82","author":"Park","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejca.2026.116593_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-17-00030.1","article-title":"Interplay effect of target motion and pencil-beam scanning in proton therapy for pediatric patients","volume":"5","author":"Boria","year":"2018","journal-title":"Int J Part Ther"},{"issue":"3","key":"10.1016\/j.ejca.2026.116593_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejca.2026.116593_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2018.12.013","article-title":"Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma","volume":"131","author":"Kim","year":"2019","journal-title":"Radio Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2026.116593_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1200\/JCO-24-01532","article-title":"Radiofrequency ablation versus stereotactic body radiotherapy for recurrent small hepatocellular carcinoma: a randomized, open-label, controlled trial","volume":"43","author":"Xi","year":"2025","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2026.116593_bib35","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/cncr.34965","article-title":"Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial","volume":"129","author":"Bush","year":"2023","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.ejca.2026.116593_bib36","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejca.2026.116593_bib37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.ejca.2026.116593_bib38","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"issue":"5","key":"10.1016\/j.ejca.2026.116593_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"issue":"2","key":"10.1016\/j.ejca.2026.116593_bib40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.17998\/jlc.2024.06.26","article-title":"Recent update of proton beam therapy for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"24","author":"Bae","year":"2024","journal-title":"J Liver Cancer"},{"key":"10.1016\/j.ejca.2026.116593_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2018.12.012","article-title":"Patient specific outcomes of charged particle therapy for hepatocellular carcinoma\u2013a systematic review and quantitative analysis","volume":"132","author":"Spychalski","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926003734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926003734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:34:59Z","timestamp":1778517299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926003734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"alternative-id":["S0959804926003734"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116593","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116593"}}